Cerubidine (daunorubicin): an update ; proceedings of a symposium held May 5, 1984, Toronto, Canada
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Orlando, FL
Grune & Stratton
1984
|
Schriftenreihe: | Seminars in oncology
11,4, Suppl. 3 |
Schlagworte: | |
Beschreibung: | 79 S. graph. Darst. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV001058121 | ||
003 | DE-604 | ||
005 | 20130618 | ||
007 | t | ||
008 | 890315s1984 d||| |||| 10||| eng d | ||
035 | |a (OCoLC)11643642 | ||
035 | |a (DE-599)BVBBV001058121 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-19 | ||
245 | 1 | 0 | |a Cerubidine (daunorubicin) |b an update ; proceedings of a symposium held May 5, 1984, Toronto, Canada |c [contributors Peter H. Wiernik ...] |
264 | 1 | |a Orlando, FL |b Grune & Stratton |c 1984 | |
300 | |a 79 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Seminars in oncology |v 11,4, Suppl. 3 | |
650 | 4 | |a Daunorubicin |x pharmacology |v Congresses | |
650 | 4 | |a Daunorubicin |x therapeutic use |v Congresses | |
650 | 4 | |a Leukemia |x drug therapy |v Congresses | |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
700 | 1 | |a Wiernik, Peter H. |e Sonstige |0 (DE-588)13763451X |4 oth | |
999 | |a oai:aleph.bib-bvb.de:BVB01-000640026 |
Datensatz im Suchindex
_version_ | 1804115475812057088 |
---|---|
any_adam_object | |
author_GND | (DE-588)13763451X |
building | Verbundindex |
bvnumber | BV001058121 |
ctrlnum | (OCoLC)11643642 (DE-599)BVBBV001058121 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01050nam a2200301 cb4500</leader><controlfield tag="001">BV001058121</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130618 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">890315s1984 d||| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)11643642</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV001058121</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cerubidine (daunorubicin)</subfield><subfield code="b">an update ; proceedings of a symposium held May 5, 1984, Toronto, Canada</subfield><subfield code="c">[contributors Peter H. Wiernik ...]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Orlando, FL</subfield><subfield code="b">Grune & Stratton</subfield><subfield code="c">1984</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">79 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Seminars in oncology</subfield><subfield code="v">11,4, Suppl. 3</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Daunorubicin</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Daunorubicin</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Leukemia</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wiernik, Peter H.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)13763451X</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000640026</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Konferenzschrift |
id | DE-604.BV001058121 |
illustrated | Illustrated |
indexdate | 2024-07-09T15:23:13Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000640026 |
oclc_num | 11643642 |
open_access_boolean | |
owner | DE-19 DE-BY-UBM |
owner_facet | DE-19 DE-BY-UBM |
physical | 79 S. graph. Darst. |
publishDate | 1984 |
publishDateSearch | 1984 |
publishDateSort | 1984 |
publisher | Grune & Stratton |
record_format | marc |
series2 | Seminars in oncology |
spelling | Cerubidine (daunorubicin) an update ; proceedings of a symposium held May 5, 1984, Toronto, Canada [contributors Peter H. Wiernik ...] Orlando, FL Grune & Stratton 1984 79 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Seminars in oncology 11,4, Suppl. 3 Daunorubicin pharmacology Congresses Daunorubicin therapeutic use Congresses Leukemia drug therapy Congresses (DE-588)1071861417 Konferenzschrift gnd-content Wiernik, Peter H. Sonstige (DE-588)13763451X oth |
spellingShingle | Cerubidine (daunorubicin) an update ; proceedings of a symposium held May 5, 1984, Toronto, Canada Daunorubicin pharmacology Congresses Daunorubicin therapeutic use Congresses Leukemia drug therapy Congresses |
subject_GND | (DE-588)1071861417 |
title | Cerubidine (daunorubicin) an update ; proceedings of a symposium held May 5, 1984, Toronto, Canada |
title_auth | Cerubidine (daunorubicin) an update ; proceedings of a symposium held May 5, 1984, Toronto, Canada |
title_exact_search | Cerubidine (daunorubicin) an update ; proceedings of a symposium held May 5, 1984, Toronto, Canada |
title_full | Cerubidine (daunorubicin) an update ; proceedings of a symposium held May 5, 1984, Toronto, Canada [contributors Peter H. Wiernik ...] |
title_fullStr | Cerubidine (daunorubicin) an update ; proceedings of a symposium held May 5, 1984, Toronto, Canada [contributors Peter H. Wiernik ...] |
title_full_unstemmed | Cerubidine (daunorubicin) an update ; proceedings of a symposium held May 5, 1984, Toronto, Canada [contributors Peter H. Wiernik ...] |
title_short | Cerubidine (daunorubicin) |
title_sort | cerubidine daunorubicin an update proceedings of a symposium held may 5 1984 toronto canada |
title_sub | an update ; proceedings of a symposium held May 5, 1984, Toronto, Canada |
topic | Daunorubicin pharmacology Congresses Daunorubicin therapeutic use Congresses Leukemia drug therapy Congresses |
topic_facet | Daunorubicin pharmacology Congresses Daunorubicin therapeutic use Congresses Leukemia drug therapy Congresses Konferenzschrift |
work_keys_str_mv | AT wiernikpeterh cerubidinedaunorubicinanupdateproceedingsofasymposiumheldmay51984torontocanada |